Seroepidemiology of varicella among the healthy population aged 1-19 years in Harbin, China.
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Xi-Kun LI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xiao-Li GAO
			        		
			        		;
		        		
		        		
		        		
			        		Yan LI
			        		
			        		;
		        		
		        		
		        		
			        		Hong XU
			        		
			        		;
		        		
		        		
		        		
			        		Chen-Lu FAN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Division of Immunization Program, Harbin Center for Disease Control and Prevention, Harbin 150056, China. 390658861@qq.com.
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Adolescent;
				        		
			        		
				        		
					        		Adult;
				        		
			        		
				        		
					        		Antibodies, Viral;
				        		
			        		
				        		
					        		Chickenpox;
				        		
			        		
				        		
					        		epidemiology;
				        		
			        		
				        		
					        		Child;
				        		
			        		
				        		
					        		Child, Preschool;
				        		
			        		
				        		
					        		China;
				        		
			        		
				        		
					        		epidemiology;
				        		
			        		
				        		
					        		Herpesvirus 3, Human;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Immunoglobulin G;
				        		
			        		
				        		
					        		Infant;
				        		
			        		
				        		
					        		Seroepidemiologic Studies;
				        		
			        		
				        		
					        		Young Adult
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:
	            		
	            			Chinese Journal of Contemporary Pediatrics
	            		
	            		 2019;21(3):203-207
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	OBJECTIVE:To investigate the level of IgG antibody to varicella in the healthy population aged 1-19 years in Harbin, China.
				        	
				        
				        	METHODS:Random sampling was performed to select 1 203 healthy individuals aged 1-19 years in Harbin. According to age, they were divided into ≥1 years group (n=240), ≥4 years group (n=396), ≥7 years group (n=364) and 14-19 years group (n=203). Enzyme-linked immunosorbent assay was used to measure the concentration of varicella-zoster virus (VZV)-IgG antibody in serum, and a concentration of VZV-IgG antibody of ≥100 mIU/mL was considered positive, suggesting that the subject had the ability to resist VZV infection.
				        	
				        
				        	RESULTS:The overall positive rate of VZV-IgG antibody was 71.49% (860/1 203), and the concentration of VZV-IgG antibody was 447±17 mIU/mL. The concentration of VZV-IgG antibody tended to increase with age (P<0.05). The positive rate of VZV-IgG antibody in the urban population was significantly higher than that in the rural population (P<0.05). There was significant difference in the positive rate of VZV-IgG antibody between the populations with different doses of varicella vaccination (P<0.05), and the population with 2 doses of vaccination had the highest positive rate of VZV-IgG antibody. There was a significant difference in the concentration of VZV-IgG antibody between the populations with different medical histories (P<0.05), and the population with a past history of varicella had the highest concentration.
				        	
				        
				        	CONCLUSIONS:Among the healthy population aged 1-19 years in Harbin, there is a significant difference in the level of VZV-IgG antibody between the urban and rural populations, as well as between different age groups. Varicella vaccination should be strengthened in areas with a low vaccination rate and the population aged <14 years.